IMPLANON

Peak

etonogestrel

NDAIMPLANTATIONIMPLANT
Approved
Jul 2006
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
6

Mechanism of Action

ovulation, increased viscosity of the cervical mucus, and alterations in the endometrium.

Pharmacologic Class:

Progestin

Clinical Trials (5)

NCT04882137N/AWithdrawn

Barriers to Referring Adolescent Women for Etonogestrel Implant.

Started Sep 2023
0
Contraceptive Usage
NCT05994599Phase 1Completed

Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring

Started Jul 2023
36 enrolled
Healthy WomenFemaleContraception
NCT03335163Phase 1Completed

The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users

Started Mar 2018
48 enrolled
MigraineMigraine;MenstrualContraception
NCT01448291Phase 4Unknown

Effect of the Etonogestrel 0.12mg/Ethinyl Estradiol 0.015mg Vaginal Ring on Vaginal Innate and Inflammatory Biomarkers

Started Oct 2011
30 enrolled
Vaginosis, Bacterial
NCT01384331Phase 4Unknown

New Treatments for Troublesome Bleeding in Implanon Users

Started Jul 2011
200 enrolled
Menstrual Problem

Loss of Exclusivity

LOE Date
Jul 28, 2030
53 months away
Patent Expiry
Jul 28, 2030
Exclusivity Expiry
Jan 16, 2029

Patent Records (4)

Patent #ExpiryTypeUse Code
8888745
Aug 28, 2026
Product
10821277
May 31, 2027
Product
8722037
Sep 28, 2027
Product
9757552
Jul 28, 2030
Product
U-1